title: Analysis of human hematopoietic stem cell populations.
abstract: Purification of human hematopoietic stem cells (HSC) may be useful clinically for preparation of tumor-free grafts to be used for autologous transplantation and as targets for gene therapy. To analyze the phenotype of the human HSC, assays were used that measure the unique properties of stem cells, i.e., their long-term repopulating ability and their multilineage potential. These assays include: (1) an in vitro long-term hematopoietic culture system, using the murine bone marrow stromal cell line SyS1, which supports both B lymphopoiesis and myelopoiesis; (2) fetal human bone grafts implanted in SCID-hu mice, in which maintenance of CD34+ cells and B and myeloid differentiative capacity of candidate stem cell populations may be measured; (3) fetal human thymus grafts in SCID-hu mice, which allow the analysis of in vivo T-cell potential of a candidate stem cell population. Stem cells in adult bone marrow (ABM) or cytokine-mobilized peripheral blood (MPB) are thought to express CD34 but lack expression of markers indicating lineage commitment. This CD34+ Lineage- (Lin-) subpopulation has been isolated by fluorescence-activated cell sorting and tested for activity in the assays described here. CD34+ Lin- cells from both ABM and MPB demonstrated long-term engraftment in the SCID-hu bone model. This CD34+ Lin- population can be subfractionated further using an antibody to Thy-1. The Thy-1+ subset of CD34+Lin- cells is enriched for both long-term culture-initiating cells (LTC-1C) and has the ability to engraft in vivo.
authors.affiliation: SyStemix Inc., Palo Alto, California 94304, USA.
authors.forename: L
authors.initials: L
authors.lastname: Murray
authors.forename: D
authors.initials: D
authors.lastname: DiGiusto
authors.forename: B
authors.initials: B
authors.lastname: Chen
authors.forename: S
authors.initials: S
authors.lastname: Chen
authors.forename: J
authors.initials: J
authors.lastname: Combs
authors.forename: A
authors.initials: A
authors.lastname: Conti
authors.forename: A
authors.initials: A
authors.lastname: Galy
authors.forename: R
authors.initials: R
authors.lastname: Negrin
authors.forename: G
authors.initials: G
authors.lastname: Tricot
authors.forename: A
authors.initials: A
authors.lastname: Tsukamoto
mesh_terms: D000818:Animals; D015703:Antigens, CD / Q000032:analysis; D018952:Antigens, CD34; D015415:Biomarkers; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D016025:Bone Transplantation; D002678:Chimera; D003520:Cyclophosphamide / Q000494:pharmacology; D005047:Etoposide / Q000494:pharmacology; D016332:Fetal Tissue Transplantation; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology; D006410:Hematopoiesis / Q000187:drug effects; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells; D006801:Humans; D016130:Immunophenotyping; D051379:Mice; D016513:Mice, SCID; D009369:Neoplasms / Q000473:pathology; D018800:Thy-1 Antigens / Q000032:analysis; D013950:Thymus Gland / Q000196:embryology / Q000637:transplantation; D014183:Transplantation, Heterologous
chemical_list: D015703:Antigens, CD; D018952:Antigens, CD34; D015415:Biomarkers; D018800:Thy-1 Antigens; D016179:Granulocyte Colony-Stimulating Factor; D005047:Etoposide; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D003520:Cyclophosphamide